Giving Credit Where Credit Is Due on Breast Cancer Coverage

When a reporter gets it right, they should be complimented. I didn't get around to reading the New York Times' Science section until tonight. But I was pleasantly surprised by Denise Grady's hardnosed story on drugs like tamoxifen and raloxifene (Evista) that reduce the risk of breast cancer. She carefully laid out the relatively low absolute risks most women face, which put these preventive pharmaceutical strategies in their proper context. We armchair journalism critics are quick to blame and don't often praise reporters when they get it right. She did. And it's a good read, too.